Navigation Links
JCI online ahead of print table of contents for April 24, 2014

Ex vivo expansion of hematopoietic stem cells from cord blood

Compared to hematopoietic stem cells (HSCs) isolated from adults, HSCs isolated from cord blood (CB) have enhanced proliferative potential and can lead to hematological reconstitution when engrafted in children with hematological malignancies or genetic defects. Unfortunately, small numbers of HSCs are present in single CB collections, limiting their use as grafts for adults. For several decades investigators have used a variety of strategies to expand the numbers of CB HSC ex vivo with limited success. Evidence indicates that accumulation of epigenetic modifications influences preservation of stem cell characteristics in HSC daughter cells; therefore, in this issue of the Journal of Clinical Investigation, Pratima Chaurasia and colleagues at Mount Sinai School of Medicine expanded CB HSCs in the presence of histone deacetylase inhibitors (HDACIs) and evaluated their characteristics. Valproic acid (VPA)-treated CB HSCs produced greater numbers of HSCs that expressed several pluripotency genes. Compared to conventionally expanded CB HSCs, VPA-treated HSCs were more efficient in repopulating the bone marrow and establishing hematopoietic populations in immune deficient mice. In an accompanying Commentary, Hal Broxmeyer of the Indiana University School of Medicine discusses how these findings enhance our understanding of HSC function and could provide clinical benefit.

TITLE: Epigenetic reprogramming induces the expansion of cord blood stem cells

AUTHOR CONTACT: Ronald Hoffman
Mount Sinai School of Medicine, New York, NY, USA
Phone: 212-241-1948; Fax: 212-876-5276; E-mail:


Pratima Chaurasia
Mount Sinai School of Medicine, New York, NY, USA
Phone: 212.241.1766; Fax: 212.876.5276; E-mail:

View this article at:


TITLE: Inhibiting HDAC for human hematopoietic stem cell expansion

AUTHOR CONTACT: Hal E. Broxmeyer
Indiana University School of Medicine, Indianapolis, IN, USA
Phone: 317-274-7504 (Tel); Fax: 317-274-7592; E-mail:

View this article at:

Receptors in the brain mediate the weight loss effects of GLP1 agonists

Glucagon-like peptide-1 (GLP1) analogs are able to achieve both weight loss and glucose tolerance, both of which are crucial for controlling type 2 diabetes (T2D). GLP1 receptors (GLP1Rs) are present in the brain, but it is not clear if the brain does indeed mediate the weight loss and glucose lowering effects of GLP1 analogs. In this issue of the Journal of Clinical Investigation, Stephanie Sisley and colleagues at Cincinnati Children's Hospital Medical Center evaluated the effects of the GLP1 agonist liraglutide in animals lacking GLP1R in the central nervous system (CNS) or in visceral nerves and found that liraglutide had no effect on weight loss or food intake in these animals, even those fed a high fat diet. Interestingly, liragludtie administration did lower glucose levels in animals lacking GLP1R in either the CNS or visceral nerves. Together, these data indicate that neuronal GLP1Rs mediate weight loss and anorectic effects, but do not mediate glucose lowering.

TITLE: Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect

AUTHOR CONTACT: Stephanie Sisley
Baylor College of Medicine, Houston, TX, USA
Phone: 513-465-8701; Fax: 713-798-7057; E-mail:

View this article at:


TITLE: Epac1dependent phospholamban phosphorylation mediates the cardiac response to stresses

AUTHOR CONTACT: Satoshi Okumura
Tsurumi University, Yokohama, UNK, JPN
Phone: 011-81-45-580-8476; Fax: 011-81-45-585-2889; E-mail:

View this article at:


TITLE: Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance

Harvard Medical School, Boston, MA, USA
Phone: 617/432-3974; Fax: 617-432-3969; E-mail:

View this article at:

TITLE: The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation

McGill University, Montreal, PQ, CAN
Phone: 514-398-1521; E-mail:

View this article at:

TITLE: ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism

AUTHOR CONTACT: Jonathan Kurie
University of Texas MD Anderson Cancer Center, Houston, TX, USA
Phone: 713-745-6747; Fax: 713-792-1220; E-mail:


Yanan Yang
Mayo Clinic, Rochester, MN, USA
Phone: 507.284.8754; Fax: 507.284.9207; E-mail:

View this article at:


TITLE: Intrinsic TGF-β signaling promotes age-dependent CD8+ T cell polyfunctionality attrition

George Washington University, Washington, DC, USA
Phone: 202.994.2863; Fax: 202.994.2913; E-mail:

View this article at:


TITLE: Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination

Instituto de Biologia Molecular e Celular, Porto, , PRT
Phone: 00351226074900; Fax: ; E-mail:

View this article at:


TITLE: Estrogen promotes Leydig cell engulfment by macrophages in male infertility

State Key Laboratory of Agro-Biotechnology, Beijing, CHN
Phone: 86-1062734389; E-mail:

View this article at:


Contact: Corinne Williams
Journal of Clinical Investigation

Related medicine news :

1. UCSF launches groundbreaking online registry to drive brain disease research
2. JCI online ahead of print table of contents for March 18, 2014
3. JCI online ahead of print table of contents for March 10, 2014
4. JCI online ahead of print table of contents for Feb. 24, 2014
5. Strong religious beliefs may drive self-perception of addiction to online pornography
6. Online comments can undermine anti-smoking PSAs
7. Global In Vitro Diagnostics (IVD) Market 2013
8. Industry Analysis, Size, Share, Growth, Trends and Forecast Research Report Available Online by
9. Online Physician Disability Insurance Quotes from Dr. Disability
10. Best Business Insurance Prices Now Generated for Companies Online Through New Database Tool
11. Average Business Insurance Cost Now Calculated for Small Business Owners Online
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: